Amalus Therapeutics Denmark ApS — Credit Rating and Financial Key Figures
CVR number: 44240238
Østbanegade 123, 2100 København Ø
bart.roman@amalustherapeutics.com
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | - 313.23 |
| EBIT | - 313.23 |
| Other financial income | 265.03 |
| Other financial expenses | - 360.58 |
| Pre-tax profit | - 408.79 |
| Net earnings | - 408.79 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current amounts owed by group member comp. | 3 614.20 |
| Current other receivables | 5.17 |
| Short term receivables total | 3 619.37 |
| Cash and bank deposits | 414.93 |
| Cash and cash equivalents | 414.93 |
| Balance sheet total (assets) | 4 034.31 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | - 408.79 |
| Shareholders equity total | - 368.79 |
| Non-current deferred tax liabilities | 4 359.72 |
| Non-current liabilities total | 4 359.72 |
| Current trade creditors | 43.38 |
| Current liabilities total | 43.38 |
| Balance sheet total (liabilities) | 4 034.31 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.